Back
DexCom 10K Form
Buy
62
DXCM
DexCom
Last Price:
136.98
Seasonality Move:
13.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-10-26 | 10Q | DXCM/DexCom Quarterly |
| 2023-07-27 | 10Q | DXCM/DexCom Quarterly |
| 2023-04-27 | 10Q | DXCM/DexCom Quarterly |
| 2022-10-27 | 10Q | DXCM/DexCom Quarterly |
| 2022-07-28 | 10Q | DXCM/DexCom Quarterly |
| 2022-04-28 | 10Q | DXCM/DexCom Quarterly |
Receive DXCM News And Ratings
See the #1 stock for the next 7 days that we like better than DXCM
DXCM Financial Statistics
Sales & Book Value
| Annual Sales: | $3.62B |
|---|---|
| Cash Flow: | $81.1M |
| Price / Cash Flow: | 111.33 |
| Annual Sales: | $5.37 |
| Price / Book: | 25.08 |
Profitability
| EPS (TTM): | 1.31000 |
|---|---|
| Net Income (TTM): | $541.5M |
| Gross Margin: | $2.29B |
| Return on Equity: | 25.07% |
| Return on Assets: | 8.85% |
DexCom Earnings Forecast
Key DexCom Financial Ratios
- The Gross Profit Margin over the past 19 years for DXCM is 63.19%.
- The Selling, General & Administrative Expenses for DXCM have been equal to 32.73% of Gross Profit Margin.
- The Research & Development expenses have been 13.96% of Revenue.
- The Interest Expense is 3.75% of Operating Income.
- The Net Earning history of DXCM is 14.95% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 12 years.
DexCom Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Current Symbol: | DXCM |
| CUSIP: | 252131 |
| Website: | dexcom.com |
Debt
| Debt-to-Equity Ratio: | 1.18 |
|---|---|
| Current Ratio: | 2.84 |
| Quick Ratio: | 2.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 103.52 |
|---|---|
| Forward P/E Ratio: | 60.74 |